Postmarket data collection for psychedelic therapies risks becoming a fragmented, incompatible patchwork unless common data elements are established before registries are built, stakeholders warned.
Postmarket data collection for psychedelic therapies risks becoming a fragmented, incompatible patchwork unless common data elements are established before registries are built, stakeholders warned.